Fortrea Holdings (FTRE) Gross Profit (2022 - 2026)
Fortrea Holdings (FTRE) reported Gross Profit of $123.6 million for Q1 2026, up 6.09% on a YoY basis from $116.5 million in Q1 2025, and down 5.72% quarter-over-quarter from $131.1 million in Q4 2025.
Fortrea Holdings (FTRE) Gross Profit (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Gross Profit for 5 years, with the latest figure at $123.6 million in Q1 2026.
- For the quarter ending Q1 2026, Gross Profit rose 6.09% year-over-year to $123.6 million; the trailing twelve-month figure through Mar 2026 stood at $510.9 million (down 5.88% YoY), and the FY2025 full-year result was $503.8 million, down 5.69% from the prior year.
- Gross Profit for Q1 2026 stood at $123.6 million, down from $131.1 million in the prior quarter.
- The five-year high for Gross Profit was $237.6 million in Q4 2022, with the low at $107.9 million in Q1 2024.
- Historically, Gross Profit has averaged $146.0 million across 5 years, with a median of $139.0 million in 2024.
- Annual changes were most pronounced in 2023 — Gross Profit tumbled 44.53% — and 2025, when it climbed 7.97%.
- Fortrea Holdings' Gross Profit stood at $237.6 million in 2022, then plunged by 44.53% to $131.8 million in 2023, then gained by 6.9% to $140.9 million in 2024, then decreased by 6.96% to $131.1 million in 2025, then slipped by 5.72% to $123.6 million in 2026.
- The last three Gross Profit figures came in at $123.6 million (Q1 2026), $131.1 million (Q4 2025), and $122.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 123.60 Mn |
| Mar 31, 2026 | 123.60 Mn |
| Dec 31, 2025 | 131.10 Mn |
| Dec 31, 2025 | 131.10 Mn |
| Sep 30, 2025 | 122.70 Mn |
| Sep 30, 2025 | 122.70 Mn |
| Jun 30, 2025 | 133.50 Mn |
| Jun 30, 2025 | 133.50 Mn |
| Mar 31, 2025 | 116.50 Mn |
| Mar 31, 2025 | 116.50 Mn |
| Dec 31, 2024 | 140.90 Mn |
| Dec 31, 2024 | 140.90 Mn |
| Sep 30, 2024 | 148.30 Mn |
| Sep 30, 2024 | 148.30 Mn |
| Jun 30, 2024 | 137.10 Mn |
| Jun 30, 2024 | 137.10 Mn |
| Mar 31, 2024 | 107.90 Mn |
| Mar 31, 2024 | 107.90 Mn |
| Dec 31, 2023 | 131.80 Mn |
| Dec 31, 2023 | 131.80 Mn |